Log In
BCIQ
Print this Print this
 

Vaprisol Premixed in 5% Dextrose (conivaptan hydrochloride injection)

  Manage Alerts
Collapse Summary General Information
Company Astellas Pharma Inc.
DescriptionDual vasopressin V1a receptor and vasopressin V2 receptor antagonist
Molecular Target Vasopressin 1 (V1) receptor ; Vasopressin 2 (V2) receptor
Mechanism of ActionVasopressin 1 (V1) receptor antagonist; Vasopressin 2 (V2) receptor antagonist
Therapeutic Modality 
Latest Stage of DevelopmentMarketed
Standard IndicationHyponatremia
Indication DetailsTreat euvolemic and hypervolemic hyponatremia in hospitalized patients
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today